Pharmaceutical · Fiscal year end Mar 31

Nippon Shinyaku Co.,Ltd.

4516

日本新薬株式会社

FIGI BBG000BJV0194516.T4516 JPCorp. no. 2130001012236

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-14

For the first half of the fiscal year to 2026-03: Revenue ¥79.6 billion (+0.4% YoY), Profit before tax ¥20 billion (+10.1% YoY), Net income ¥15.8 billion (-3.7% YoY).

	This period	Year on year
Revenue	¥79.6bn	+0.4%
Profit before tax	¥20.0bn	+10.1%
Net profit to owners	¥15.8bn	-3.7%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4516/earnings-releases.

Financials

IFRS · consolidated · fiscal year to 2026-03-31

Revenue: ¥170.8bn
Net income: ¥29.7bn
ROE: 11.0%
Equity ratio: 84.2%
Dividend / share: ¥124
Employees: 2,309

Revenue · ¥bn

Net income · ¥bn

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2026-03-31	¥170.8bn	¥29.7bn	¥346.4bn	¥291.6bn	11.0%	¥441	¥27.2bn
2025-03-31	¥160.2bn	¥32.6bn	¥283.6bn	¥247.0bn	13.9%	¥483.4	¥36.1bn
2024-03-31	¥148.3bn	¥25.9bn	¥263.4bn	¥220.2bn	12.4%	¥383.82	¥16.3bn
2023-03-31	¥144.2bn	¥22.8bn	¥237.5bn	¥195.6bn	12.1%	¥338.7	¥26.2bn
2022-03-31	¥137.5bn	¥25.0bn	¥219.9bn	¥176.8bn	14.5%	¥370.97	¥16.0bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31

Metric	Value	Percentile among listed companies
ROE, %	11	63.4
Ordinary margin	0.2135	91.4
Equity ratio, %	84.2	94.3
Revenue growth	0.0658	57.5
Net income growth	-0.0871	28.8
Operating cash flow / assets	0.0786	60.2

Policy-uncertainty measure1.14 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Regulation 2 Politics & geopolitics 2

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 13.8% held by other listed companies.

Results wording balance: +0.41. Proprietary text method; it describes the wording only and does not interpret context.

Via /v1/companies/4516/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-06-23: see filing 上記の評価手続を実施した結果、2026年3月31日現在の当社グループの財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Segments: Pharmaceuticals, Functional Food. /v1/companies/4516/segments

Latest voting result: 2026-06-26 · 剰余金の処分の件 · passed. /v1/companies/4516/voting

Ownership changes

All companies →

2026-08-06

Below 5%−2.52pt

Nomura Securities Co.,Ltd. cut holdings in Nippon Shinyaku Co.,Ltd. (4516) to 4.42% from 6.94%, below the 5% threshold.

S100YU7VFiler profile Original filing (PDF, Japanese)
2025-12-18

Increase+1.91pt

Nomura Securities Co.,Ltd. raised holdings in Nippon Shinyaku Co.,Ltd. (4516) to 6.94% from 5.03%.

S100XBC7Filer profile Original filing (PDF, Japanese)
2025-04-04

New 5% stake

Nomura Securities Co.,Ltd. disclosed a 5.03% stake in Nippon Shinyaku Co.,Ltd. (4516), crossing the 5% reporting threshold.

S100VKBZFiler profile Original filing (PDF, Japanese)
2024-11-20

Below 5%−1.02pt

Nomura Securities Co.,Ltd. cut holdings in Nippon Shinyaku Co.,Ltd. (4516) to 4.03% from 5.05%, below the 5% threshold.

S100UTE8Filer profile Original filing (PDF, Japanese)
2024-07-29

Increase+0.29pt

Mitsubishi UFJ Financial Group, Inc. raised holdings in Nippon Shinyaku Co.,Ltd. (4516) to 6.48% from 6.19%.

S100U3FFFiler profile Original filing (PDF, Japanese)
2024-03-05

New 5% stake

Nomura Securities Co.,Ltd. disclosed a 5.05% stake in Nippon Shinyaku Co.,Ltd. (4516), crossing the 5% reporting threshold.

S100SZZLFiler profile Original filing (PDF, Japanese)
2023-09-05

Below 5%−1.71pt

BlackRock Japan Co., Ltd. cut holdings in Nippon Shinyaku Co.,Ltd. (4516) to 3.63% from 5.34%, below the 5% threshold.

S100RST4Filer profile Original filing (PDF, Japanese)
2023-08-18

New 5% stake

BlackRock Japan Co., Ltd. disclosed a 5.34% stake in Nippon Shinyaku Co.,Ltd. (4516), crossing the 5% reporting threshold.

S100RQ1EFiler profile Original filing (PDF, Japanese)
2023-03-20

Decrease−0.17pt

Mitsubishi UFJ Financial Group, Inc. reduced holdings in Nippon Shinyaku Co.,Ltd. (4516) to 6.19% from 6.36%.

S100QE49Filer profile Original filing (PDF, Japanese)
2022-12-19

Decrease−2.21pt

Mitsubishi UFJ Financial Group, Inc. reduced holdings in Nippon Shinyaku Co.,Ltd. (4516) to 6.36% from 8.57%.

S100PSTGFiler profile Original filing (PDF, Japanese)

5% filings

Large shareholding reports on 4516

Filed	Filer	Stake	Change	Stated purpose
2026-08-06	Nomura Securities Co.,Ltd.	4.42%	−2.52pt	—
2025-12-18	Nomura Securities Co.,Ltd.	6.94%	+1.91pt	—
2025-04-04	Nomura Securities Co.,Ltd.	5.03%	—	—
2024-11-20	Nomura Securities Co.,Ltd.	4.03%	−1.02pt	—
2024-07-29	Mitsubishi UFJ Financial Group, Inc.	6.48%	+0.29pt	strategic holding
2024-03-05	Nomura Securities Co.,Ltd.	5.05%	—	—
2023-09-05	BlackRock Japan Co., Ltd.	3.63%	−1.71pt	pure investment
2023-08-18	BlackRock Japan Co., Ltd.	5.34%	—	pure investment
2023-03-20	Mitsubishi UFJ Financial Group, Inc.	6.19%	−0.17pt	strategic holding
2022-12-19	Mitsubishi UFJ Financial Group, Inc.	6.36%	−2.21pt	strategic holding

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: 24 issues
Book value: ¥55.2bn
Sold in the year: ¥4.9bn 5 issues
Bought in the year: ¥1m 1 issues
Mutual, both reports: 19
Held by listed cos.: 23

Holds	Book value	Shares vs. prior year	Mutual
Capricor Therapeutics Inc.	¥24.0bn	0.0%	no
Mitsubishi UFJ Financial Group, Inc. 8306	¥8.6bn	-31.1%	both reports
Kyoto Financial Group, Inc. 5844	¥6.5bn	0.0%	both reports
ONO PHARMACEUTICAL CO., LTD. 4528	¥2.4bn	0.0%	both reports
MEDIPAL HOLDINGS CORPORATION 7459	¥2.3bn	0.0%	both reports
Tokio Marine Holdings, Inc. 8766	¥2.0bn	-11.1%	both reports
HORIBA, Ltd. 6856	¥1.8bn	0.0%	both reports
Mitsubishi Logistics Corporation 9301	¥1.6bn	0.0%	both reports
TOHO HOLDINGS CO.,LTD. 8129	¥1.5bn	0.0%	both reports
Shimadzu Corporation 7701	¥0.8bn	0.0%	both reports

Held by: Kyoto Financial Group, Inc. 5844, Mitsubishi UFJ Financial Group, Inc. 8306, Tokio Marine Holdings, Inc. 8766, ONO PHARMACEUTICAL CO., LTD. 4528, Mitsubishi Logistics Corporation 9301, MEDIPAL HOLDINGS CORPORATION 7459, HORIBA, Ltd. 6856, GS Yuasa Corporation 6674, TAKARA HOLDINGS INC. 2531, Shimadzu Corporation 7701, 2540 2540, TAKEBISHI CORPORATION 7510 and 12 more

Purposes, all holdings and mutual flags via /v1/companies/4516/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31

Shareholder	Shares	Ratio
日本マスタートラスト信託銀行株式会社（信託口）	8,100,000	12.02%
明治安田生命保険相互会社	6,486,000	9.62%
株式会社日本カストディ銀行（信託口）	4,918,000	7.30%
株式会社京都銀行	3,090,000	4.58%
株式会社三菱ＵＦＪ銀行	2,706,000	4.02%
日本生命保険相互会社	1,341,000	1.99%
individual holder	1,284,000	1.91%
individual holder	1,170,000	1.74%
モルガン・スタンレーＭＵＦＧ証券株式会社	1,147,000	1.70%
individual holder	1,140,000	1.69%

U.S. funds holding 4516

SEC Form N-PORT, reports to 2026-07-31

92 U.S. funds held 7,008,633 shares worth $160.7m.

Fund	Shares	Value	% of fund	As of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS	890,513	$18.9m	0.003%	2026-07-31
Goldman Sachs International Small Cap Insights Fund Goldman Sachs Trust	835,300	$17.8m	0.249%	2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND VANGUARD TAX-MANAGED FUNDS	604,912	$15.0m	0.005%	2026-06-30
Avantis International Small Cap Value ETF American Century ETF Trust	489,200	$12.9m	0.065%	2026-05-31
Victory Trivalent International Small-Cap Fund Victory Portfolios	386,200	$9.6m	0.205%	2026-06-30

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4516
GET /v1/companies/4516/financials
GET /v1/companies/4516/details
GET /v1/companies/4516/segments
GET /v1/companies/4516/voting
GET /v1/companies/4516/tender-offers
GET /v1/companies/4516/indicators
GET /v1/companies/4516/earnings-releases
GET /v1/events?ticker=4516
GET /v1/companies/4516/trades         
GET /v1/companies/4516/cross-holdings 
GET /v1/companies/4516/brief

Plans from $9 a month · Documentation